THE EFFECT OF INCUBATION CONDITIONS ON THE ENZYME KINETICS OF UDP-GLUCURONOSYLTRANSFERASES
- 1 June 2003
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 31 (6) , 762-767
- https://doi.org/10.1124/dmd.31.6.762
Abstract
Traditionally, the Michaelis-Menten equation has been used to determine kinetic parameters for in vitro glucuronidation assays. Recently, estradiol-3-glucuronide formation was shown to exhibit non-Michaelis-Menten kinetics consistent with autoactivation. A concern with the observation of nontraditional kinetics is that they may result as an artifact of the incubation conditions. To examine this concern, the formation of estradiol-3-glucuronide was investigated using human liver microsomes prepared by two different methods, a range of assay conditions, and activation by alamethecin, sonication, or Brij 58 (polyoxyethylene monocetyl ether). Interestingly, holding the other assay components constant, estradiol-3-glucuronide formation was up to 2.5-fold greater using microsomes prepared in phosphate buffer compared with those prepared in sucrose. Incubations activated by alamethecin consistently exhibited the highest rates of estradiol glucuronidation versus the other activators. Furthermore, estradiol-3-glucuronidation exhibited autoactivation kinetics in all of the conditions investigated (n = 1.2–1.7). Nontraditional kinetics were also observed when other UGT1A1 substrates such as ethinylestradiol, buprenorphine, and anthraflavic acid were studied with both human liver microsomes and recombinant UGT1A1. Naphthol, propofol, morphine, and androstanediol were used as probe UGT substrates selective for UGT1A6, UGT1A9, UGT2B7, and UGT2B15, respectively. Of these substrates, only androstanediol exhibited nontraditional kinetics using human liver microsomes. In conclusion, the Hill and/or Michaelis-Menten equations should be used to fit kinetic data to obtain an accurate assessment of in vitro glucuronidation.Keywords
This publication has 26 references indexed in Scilit:
- Is There a Toxicological Advantage for Non-hyperbolic Kinetics in Cytochrome P450 Catalysis?Published by Elsevier ,2002
- Homodimerization of Human Bilirubin-Uridine-diphosphoglucuronate Glucuronosyltransferase-1 (UGT1A1) and Its Functional ImplicationsJournal of Biological Chemistry, 2001
- Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bankPharmacogenetics, 2000
- Kinetic Studies of Hepatocyte Udp-Glucuronosyltransferase: Evidence of An Allosteric EnzymeArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1999
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Evidence for the Intraluminal Positioning of p-Nitrophenol UDP-glucuronosyltransferase Activity in Rat Liver Microsomal VesiclesArchives of Biochemistry and Biophysics, 1994
- The Uridine Diphosphate Glucuronosyltransferase Multigene Family: Function and RegulationPublished by Springer Nature ,1994
- Purification and properties of rat kidney UDP-glucuronosyltransferaseBiochemical Pharmacology, 1987
- UDP-glucuronosyltransferase activitiesBiochemical Pharmacology, 1983
- Factors affecting the response of microsomal UDP-glucuronyltransferase to membrane perturbantsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973